Evidence map›Paper›PMID 40354410›Full record

ArticlePLoS computational biology2025

Knowledge-aware contrastive heterogeneous molecular graph learning.

Mukun Chen, Jia Wu, Shirui Pan, Fu Lin, Bo Du, Xiuwen Gong, Wenbin Hu

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mukun ChenSchool of Computer Science, Wuhan University, Wuhan, Hubei Province, China.ORCID 0000-0002-0511-5347
Jia WuSchool of Computing, Macquarie University, Sydney, Australia.
Shirui PanSchool of Information and Communication Technology, Griffith University, Queensland, Australia.
Fu LinSchool of Computer Science, Wuhan University, Wuhan, Hubei Province, China.
Bo DuSchool of Computer Science, Wuhan University, Wuhan, Hubei Province, China.
Xiuwen GongFaculty of Engineering and Information Technology, University of Technology Sydney, Sydney, Australia.
Wenbin HuSchool of Computer Science, Wuhan University, Wuhan, Hubei Province, China.ORCID 0000-0002-9258-3850

Funding

Guangdong Provincial Natural Science Foundation General ProjectNational Key Research and Development Program of ChinaNational Science Foundation of China
6 · The paper itself

Abstract

Molecular representation learning is pivotal in predicting molecular properties and advancing drug design. Traditional methodologies, which predominantly rely on homogeneous graph encoding, are limited by their inability to integrate external knowledge and represent molecular structures across different levels of granularity. To address these limitations, we propose a paradigm shift by encoding molecular graphs into heterogeneous structures, introducing a novel framework: Knowledge-aware Contrastive Heterogeneous Molecular Graph Learning. This approach leverages contrastive learning to enrich molecular representations with embedded external knowledge. KCHML conceptualizes molecules through three distinct graph views-molecular, elemental, and pharmacological-enhanced by heterogeneous molecular graphs and a dual message-passing mechanism. This design offers a comprehensive representation for property prediction, as well as for downstream tasks such as drug-drug interaction prediction. Extensive benchmarking demonstrates KCHML's superiority over state-of-the-art molecular property prediction models, underscoring its ability to capture intricate molecular features.

Indexed as

Computational BiologyDrug DesignMachine LearningAlgorithmsDrug InteractionsHumans

Identifiers

PMID40354410
PMCPMC12068650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.